Rehabilitation Intervention Is Associated With Improved Neurodevelopment and Modulation of Inflammatory Molecules in

Rafael Coelho Magalhães1, Roberta da Silva Filha2, Érica Leandro Marciano Vieira3,4

  • 1Department of Occupational Therapy, School of Physical Education, Physiotherapy and Occupational Therapy, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.

PubMed

Insights

Systematic rehabilitation significantly improved neurodevelopment in children with cerebral palsy. It also modulated key inflammatory and neurotrophic biomarkers, offering a comprehensive approach to managing this condition.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Immunology

Background:

  • Cerebral palsy (CP) affects neurodevelopment and is associated with altered immune and neuroplastic profiles.
  • Understanding the impact of interventions on these mediators is crucial for optimizing CP management.

Purpose of the Study:

  • To assess the effects of systematic rehabilitation on neuropsychomotor development in children with CP.
  • To evaluate changes in peripheral immunological and neuroplastic mediators following rehabilitation.

Main Methods:

  • A prospective cohort study involving 90 children with CP (18 months old).
  • Comparison between 60 children receiving 6 months of rehabilitation and 30 children on a waiting list.
  • Assessment of peripheral biomarkers and neuropsychomotor parameters at baseline and 6 months.

Main Results:

  • The rehabilitation group showed significantly higher Bayley III scores compared to the non-rehabilitation group.
  • Rehabilitation led to decreased levels of pro-inflammatory cytokines (IL-12p70, IL-6, IL-1β, CXCL8, CXCL9) and increased levels of neurotrophic factors (BDNF, GDNF).
  • The non-rehabilitation group exhibited stable immune markers but a decline in BDNF levels over time.

Conclusions:

  • Systematic rehabilitation enhances neurodevelopmental outcomes in children with cerebral palsy.
  • Rehabilitation effectively modulates peripheral inflammatory markers (reducing them) and neurotrophic factors (increasing them).
Abstract